drugset / Trial / NCT02311764
Carboplatin in Castration-resistant Prostate Cancer
Phase 2
Terminated
16 enrolled
Aurelius Omlin
Teva Pharma · collabUniversity Hospital, Zürich · collab
NaSingle-groupOpen-labelTreatment
Summary
Open label, non-randomised phase II clinical pilot study
Timeline
- Start
- 2015-02
- Primary completion
- 2019-12
- Completion
- 2019-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carboplatin | Small molecule | — | — |